Cavitation Technologies
Market Cap
US$4.4m
Last Updated
2020/02/19 01:27 UTC
Data Sources
Company Financials
Executive Summary
Cavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in liquid processing applications in the United States.
Rewards
Risk Analysis
Currently unprofitable and not forecast to become profitable over the next 3 years
Snowflake Analysis
Mediocre balance sheet with weak fundamentals.
Similar Companies
Share Price & News
How has Cavitation Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CVAT's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
0%
CVAT
-2.3%
US Electronic
0.06%
US Market
1 Year Return
-19.6%
CVAT
7.7%
US Electronic
19.4%
US Market
Return vs Industry: CVAT underperformed the US Electronic industry which returned 7.7% over the past year.
Return vs Market: CVAT underperformed the US Market which returned 19.4% over the past year.
Shareholder returns
| CVAT | Industry | Market | |
|---|---|---|---|
| 7 Day | 0% | -2.3% | 0.06% |
| 30 Day | 7.1% | -6.2% | 1.1% |
| 90 Day | -25.0% | 1.1% | 8.9% |
| 1 Year | -19.6%-19.6% | 8.8%7.7% | 21.9%19.4% |
| 3 Year | -45.1%-45.1% | 34.4%30.8% | 48.9%39.3% |
| 5 Year | -65.1%-65.1% | 66.6%58.5% | 71.9%53.1% |
Price Volatility Vs. Market
How volatile is Cavitation Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is Cavitation Technologies undervalued compared to its fair value and its price relative to the market?
Share Price vs. Fair Value
Below Fair Value: CVAT ($0.02) is trading above our estimate of fair value ($0)
Significantly Below Fair Value: CVAT is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CVAT is unprofitable, so we can't compare its PE Ratio to the Electronic industry average.
PE vs Market: CVAT is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CVAT's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CVAT has negative assets, so we can't compare its PB Ratio to the US Electronic industry average.
Next Steps
Future Growth
How is Cavitation Technologies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
21.6%
Forecasted Tech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cavitation Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Take a look at our analysis of CVAT’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Cavitation Technologies's filings and announcements here.
- Explore growth companies in the Tech industry.
Past Performance
How has Cavitation Technologies performed over the past 5 years?
28.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CVAT is currently unprofitable.
Growing Profit Margin: CVAT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CVAT is unprofitable, but has reduced losses over the past 5 years at a rate of 28.5% per year.
Accelerating Growth: Unable to compare CVAT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CVAT is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (14.6%).
Return on Equity
High ROE: CVAT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Cavitation Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: CVAT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: CVAT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: CVAT is debt free.
Reducing Debt: CVAT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Inventory Level: CVAT has a high level of physical assets or inventory.
Debt Coverage by Assets: CVAT has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CVAT has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CVAT is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 12.4% per year.
Next Steps
Dividend
What is Cavitation Technologies's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate CVAT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate CVAT's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CVAT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CVAT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CVAT's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
7.1yrs
Average management tenure
CEO
Igor Gorodnitsky (59yo)
7.3yrs
Tenure
US$173,800
Compensation
Mr. Igor Gorodnitsky Co-Founded Cavitation Technologies, Inc. on January 29, 2007 and serves as its Principal Executive Officer since November 2012. Mr. Gorodnitsky has been President of Cavitation Technol ...
CEO Compensation Analysis
Compensation vs Market: Igor's total compensation ($USD173.80K) is below average for companies of similar size in the US market ($USD519.76K).
Compensation vs Earnings: Igor's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 7.3yrs | US$173.80k | 8.76% $388.1k | |
| CFO, COO & Principal Accounting Officer | 7.1yrs | US$173.80k | 30.46% $1.3m | |
| Co-Founder & Global Technology Manager | 0yrs | US$289.00k | no data | |
| Head of Research and Director of Research & Development | 1.1yrs | no data | no data |
7.1yrs
Average Tenure
59yo
Average Age
Experienced Management: CVAT's management team is seasoned and experienced (7.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Cavitation Technologies, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Cavitation Technologies, Inc.
- Ticker: CVAT
- Exchange: OTCPK
- Founded: 2007
- Industry: Electronic Components
- Sector: Tech
- Market Cap: US$4.432m
- Shares outstanding: 197.00m
- Website: https://www.ctinanotech.com
Number of Employees
Location
- Cavitation Technologies, Inc.
- 10019 Canoga Avenue
- Chatsworth
- California
- 91311
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CVAT | OTCPK (Pink Sheets LLC) | Yes | Common Stock | US | USD | Oct 2008 |
Biography
Cavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in liquid processing applications in the United States. It offers Nano Neutralization system for refining vegetable oils, such as soybean, rapeseed, canola, and palm oil. The company also develops technology based systems that are designed to serve various markets, such as vegetable oil refining, renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions, and crude oil yield enhancement. Cavitation Technologies, Inc. was founded in 2007 and is headquartered in Chatsworth, California.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/02/19 01:27 |
| End of Day Share Price | 2020/02/11 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.